Laobaixing has rolled out a package including a share buyback, a 2026 restricted stock incentive plan, and an employee stock ownership plan. It intends to grant a total of 14.337 million shares to over 340 incentive recipients. Based on the stock price at the time of the draft announcement, the total market value of the granted shares exceeds 180 million yuan. The company has set targets using 2025 net profit as the base, requiring net profit growth rates of no less than 75 percent and 100 percent in 2027 and 2028 respectively. That means achieving net profit of 946 million yuan in 2027 and 1.081 billion yuan in 2028. Meanwhile, the company plans to use its own funds or self-raised funds to implement a share buyback through centralized bidding. The total buyback amount will range from 40 million yuan to 80 million yuan, with a buyback price not exceeding 18.08 yuan per share. The estimated number of shares to be repurchased is between 2.2123 million and 4.4247 million shares. The repurchased shares will be used for the employee stock ownership plan and equity incentives. The incentive recipients precisely cover mid-to-senior management and core teams, with a focus on talent in information and digital AI business areas, aligning with the company's digital and AI transformation strategy. A maximum 31-month vesting period and an additional 6-month lock-up period have been set to deeply align personal interests with the company's medium- and long-term development.
Laobaixing PharmacyLaobaixing launches share buyback and incentive plans targeting high profit growth.